Social media posts related to drug promotions often lack risk-related information, with many posts featuring undisclosed ...

The movie ratings board has pulled back the curtain on how it approaches hot-button topics, including nudity, marijuana and ...

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

The current analysis illustrates that drug promotion content is frequently posted by individual creators, lacks essential risk information, and bears the hallmarks of undisclosed marketing. These ...

The call is coming from inside the house: Top FDA drug regulator Richard Pazdur, who was appointed to the role earlier this month, has raised alarms about the agency’s various plans to expedite drug ...

As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...

The United States has recently designated an alleged Venezuelan cartel as a terrorist organisation. This can be bad news for ...

Eli Lilly became the first drugmaker to reach a $1 trillion market valuation on Friday, driven by the rapid growth of its ...

The settlement ends a 2023 lawsuit alleging pharmaceutical companies manipulated ADHD medication quality tests.

Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This ...